First experiments in space for COVID-19 drug research

The COVID-19 pandemic has generated new and urgent challenges in drug discovery and development. Veklury®, a remdesivir-based medicament invented by Gilead Sciences Inc., has already been approved or authorized for temporary use in approximately 50 countries worldwide. It is, at the moment, the first and only COVID-19 treatment in the United States approved by the U.S. Food and Drug Administration.

Remdesivir, to be applicable for its intravenous infusion, requires formulation by the excipient cyclodextrin called SBECD. Although it is considered today as one of the most promising drugs for COVID-19 treatment, remarkable efficacy of Veklury® (i.e., remdesivir-SBECD complex) has not yet been confirmed. Recent clinical trials, however, claimed that remdesivir was found superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19.

Hungarian companies InnoStudio Inc. and CycloLab Cyclodextrin R&D Laboratory Ltd. are going to investigate the potential effect of microgravity on the complex formation properties of remdesivir and SBECD. Dr. Ferenc Darvas, Executive President of InnoStudio; Dr. Gergo Mezohegyi, Manager of the project; Dr. Lajos Szente, co-founder of CycloLab; and Dr. Istvan Puskas, Head of formulation development stated: ”Results of this project may contribute to better understanding of the remdesivir-SBECD formulation mechanism, which will hopefully allow us to tailor the physico-chemical formulation process in order to reach elevated drug efficiency for COVID-19 treatment. Moreover, potential enhancement of the remdesivir SBECD ratio in the drug (i.e., lowering SBECD intake) will contribute to its lower risk application for coronavirus infected patients with decreased renal functions. Our study will try to combine advantages of microgravity environment with advanced drug research, while it is also a key initiative for the pharma industry to widen their development opportunities via space research.”

The companies will use research facilities of Japan Manned Space Systems Corporation (JP) and Space Applications Services (BE) and will launch their remdesivir samples to the European Space Agency’s Columbus module on the International Space Station (ISS) by the SpaceX Dragon cargo resupply mission (CRS-21) in early December, 2020.

InnoStudio already executed successful drug discovery related experiments on the ISS in December 2019. CycloLab is the lead European manufacturer of SBECD.


For more information please contact:
Dr. Gergo Mezohegyi
gergo.mezohegyi@innostudio.or

Upcoming Events

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Social Media

Follow our daily updated Social Media pages for the latest news, event,curiosities and fun.

Latest News & Events

ISSR&D CONFERENCE, August 2021

ISSR&D CONFERENCE, August 2021

We are pleased to inform you that InnoStudio will hold a presentation, entitled „Effect of microgravity on COVID-19 drug formulation on ISS” at ISSRDC 2021, the 10th Annual International Space Station Research and Development Conference on August 16 in the Biology and...

ESA In-Orbit Economy workshop July 20, 2021

ESA In-Orbit Economy workshop July 20, 2021

We are honored to be invited to ESA’s upcoming workshop “In-Orbit Economy” on July 20, 2021, from 9:45AM to 13:00PM CEST, live on WebEx. President & CEO Dr. Ferenc Darvas will join the roundtable discussion and talk about how to bridge the gap between zero gravity...

Hungarians develop more effective COVID drugs in space

Hungarians develop more effective COVID drugs in space

Published May 7, 2021 on 24.hu In the last few months, in addition to vaccine developments against the coronavirus, little has been heard of regarding what efforts have been made to develop new medicines for the treatment of already covid infected patients. Regarding...

Latest Articles

We are at the forefront of space research (article in Hungarian)

We are at the forefront of space research (article in Hungarian)

Chemistry as a science is strongly underrepresented in the space industry, although it can provide answers to problems such as more environmentally conscious, cheaper rocket fuel, renewable, green energy on Earth and in space, pharmaceutical production, carbon use,...